232 related articles for article (PubMed ID: 16019537)
1. Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab.
Robak E; Biernat W; Krykowski E; Jeziorski A; Robak T
Leuk Lymphoma; 2005 Jun; 46(6):909-14. PubMed ID: 16019537
[TBL] [Abstract][Full Text] [Related]
2. A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment.
Papageorgiou KI; Kaniorou-Larai MG
BMC Cancer; 2005 Aug; 5():106. PubMed ID: 16111484
[TBL] [Abstract][Full Text] [Related]
3. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Robak P; Linke A; Cebula B; Robak T; Smolewski P
Leuk Lymphoma; 2006 Dec; 47(12):2625-34. PubMed ID: 17169808
[TBL] [Abstract][Full Text] [Related]
5. Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinoma.
Craig PJ; Calonje JE; Harries M; Stefanato CM
J Cutan Pathol; 2009 Jun; 36(6):706-10. PubMed ID: 19519600
[TBL] [Abstract][Full Text] [Related]
6. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ
Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia.
Robak E; Robak T; Biernat W; Bartkowiak J; Krykowski E
Br J Dermatol; 2002 Oct; 147(4):775-80. PubMed ID: 12366429
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
Papalas JA; McKinney MS; Kulbacki E; Dave SS; Wang E
Am J Dermatopathol; 2014 Feb; 36(2):148-52. PubMed ID: 24556900
[TBL] [Abstract][Full Text] [Related]
9. Collision tumor of primary merkel cell carcinoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, diagnosed on ultrasound-guided fine-needle aspiration biopsy: a unique case report and review of literature.
Li Z; Yang JJ; Wu M
Diagn Cytopathol; 2015 Jan; 43(1):66-71. PubMed ID: 24610800
[TBL] [Abstract][Full Text] [Related]
10. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
11. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
12. Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
Bertazzoni P; Rabascio C; Gigli F; Calabrese L; Radice D; Calleri A; Gregato G; Negri M; Liptrott SJ; Bassi S; Nassi L; Sammassimo S; Laszlo D; Preda L; Pruneri G; Orlando L; Martinelli G
Leuk Lymphoma; 2010 Aug; 51(8):1485-93. PubMed ID: 20578816
[TBL] [Abstract][Full Text] [Related]
13. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
15. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
Robak T; Smolewski P; Urbanska-Rys H; Gora-Tybor J; Blonski JZ; Kasznicki M
Leuk Lymphoma; 2004 May; 45(5):937-44. PubMed ID: 15291352
[TBL] [Abstract][Full Text] [Related]
16. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Nabhan C; Gartenhaus RB; Tallman MS
Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy.
Srock S; Schriever F; Neubauer A; Herold M; Huhn D
Leuk Lymphoma; 2007 May; 48(5):905-11. PubMed ID: 17487734
[TBL] [Abstract][Full Text] [Related]
18. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.
Robak T; Urbańska-Ryś H; Strzelecka B; Krykowski E; Bartkowiak J; Bĺoński JZ; Kordek R; Warzocha K
Eur J Haematol; 2001; 67(5-6):322-7. PubMed ID: 11872081
[TBL] [Abstract][Full Text] [Related]
19. [Merkel cell carcinoma in a patient with chronic lymphocytic leukemia].
Cervigón I; Gargallo AB; Bahillo C; Martínez-Amo JL; Orradre JL; Muñoz-Madero V; García-Almagro D
Actas Dermosifiliogr; 2006 May; 97(4):264-6. PubMed ID: 16801021
[TBL] [Abstract][Full Text] [Related]
20. Rituximab dose-escalation trial in chronic lymphocytic leukemia.
O'Brien SM; Kantarjian H; Thomas DA; Giles FJ; Freireich EJ; Cortes J; Lerner S; Keating MJ
J Clin Oncol; 2001 Apr; 19(8):2165-70. PubMed ID: 11304768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
